Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12703/P7-55 http://scihub22266oqcxt.onion/10.12703/P7-55 C4447031!4447031!26097728     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       F1000Prime+Rep 2015 ; 7 (ä): ä Nephropedia Template TP {{tp|p=26097728|t=2015. Recent advances in understanding and managing leiomyosarcomas |pdf=|usr=}}{{26097728}} gab.com Text Recent advances in understanding and managing leiomyosarcomas JO: F1000Prime Rep http://www.kidney.de/pget.php?&tw=1&pmid=26097728 #FOAvip Leiomyosarcomas are malignant mesenchymal tumours that derive from the smooth muscle lineage. They are studied and frequently treated as if they are the same as other soft tissue sarcomas. Recent developments suggest that a different approach may be more appropriate. Their underlying genetic mechanisms remain unclear, and complex. Unbalanced karyotypic defects are the only shared features observed across different leiomyosarcoma subtypes. Unlike other soft tissue sarcomas, leiomyosarcomas are particularly sensitive to the combination of gemcitabine and docetaxel. Furthermore, treatment with trabectedin has shown a good efficacy in leiomyosarcomas, mainly in the form of chronic disease stabilisation. Twit Text FOAVip Recent advances in understanding and managing leiomyosarcomas ????F1000Prime Rep http://www.kidney.de/pget.php?&tw=1&pmid=26097728 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26097728 #FOAvip English Wikipedia <ref>{{Cite pmid|26097728}}</ref> Recent advances in understanding and managing leiomyosarcomas #MMPMID26097728 Duffaud F; Ray-Coquard I; Salas S; Pautier P F1000Prime Rep 2015[]; 7 (ä): ä PMID26097728show ga Leiomyosarcomas are malignant mesenchymal tumours that derive from the smooth muscle lineage. They are studied and frequently treated as if they are the same as other soft tissue sarcomas. Recent developments suggest that a different approach may be more appropriate. Their underlying genetic mechanisms remain unclear, and complex. Unbalanced karyotypic defects are the only shared features observed across different leiomyosarcoma subtypes. Unlike other soft tissue sarcomas, leiomyosarcomas are particularly sensitive to the combination of gemcitabine and docetaxel. Furthermore, treatment with trabectedin has shown a good efficacy in leiomyosarcomas, mainly in the form of chronic disease stabilisation. äRecent advances in understanding and managing leiomyosarcomas (epmc).pdf DeepDyve Pubget Overpricing